MEDVi, Hers, and PlexusDx price GLP-1 care three different ways: MEDVi with an introductory month and a recurring refill rate, Hers with a membership billed apart from branded medication, and PlexusDx with one flat monthly price. This comparison uses each company's own pages as of September 22, 2026 and keeps compounded and branded products separate.

MEDVi vs Gala GLP-1 vs PlexusDx compared on verified 2026 pricing, compounded vs FDA-approved status, cancellation rules, and where a genetic baseline changes the dose decision before week one.

MEDVi's compounded semaglutide injection uses a lower first-month rate for new patients and a higher recurring refill rate. This guide separates the two, shows what the price includes, explains cancellation terms, and compares the same injection plan type against PlexusDx month-to-month and over 3, 6, and 12 billing cycles.

MEDVi sells two different oral routes under one banner: a compounded semaglutide dissolvable tablet priced about $70 a month over MEDVi's injection rate (no tablet total published), and a branded Wegovy pill pathway billed as membership plus medication. This review separates the two, explains what FDA approval does and does not cover, and compares them with PlexusDx oral options.

Is GLP-1 HRA, FSA, or HSA eligible? Often yes when prescribed for a diagnosed condition, but the rules vary by plan. Here is the framework, the documentation you need, and where PlexusDx Weight Management Protocols (from $129/mo, all 50 states, no membership) fit when your account does not cover GLP-1s for weight loss.

Florida residents can legally start GLP-1 telehealth in days under Statute §456.47. We compare MEDVi, Ro, Walgreens, and the PlexusDx Microdose GLP-1 Protocol from $129/mo — with a genetic baseline option no other Florida provider offers.

Constipation is one of the most common GLP-1 side effects — here's the food, fluid, movement, and dose-adjustment playbook that actually works, plus where the PlexusDx Microdose GLP-1 Protocol and Precision Peptide Genetic Test fit in.

The honest list of GLP-1 options under $200/mo in April 2026 is much shorter than the ads suggest. PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest under-$200 option in this comparison, with PlexusDx Semaglutide Injection at $189/mo month-to-month (or $149/mo on the 6-month plan) as the lowest weekly compounded semaglutide path. FDA-approved Foundayo and the Wegovy pill start at $149/mo at lower doses but escalate with dose; most other “$199 GLP-1” ads are first-month-only promos that jump to $249–$349 on refill.

Pennsylvania Medicaid cut GLP-1 coverage for adult weight loss on January 1, 2026. This guide walks the legal cash-pay telehealth options that ship to PA, the compounded vs FDA-approved branded distinction, real annualized costs, and where PlexusDx Microdose GLP-1 ($129/mo), Semaglutide Injection ($189/mo), and Tirzepatide Injection ($289/mo) sit relative to Eden, Ro, TrimRx, Willow, and MEDVi — with the optional Precision Peptide Genetic Test adding pathway-level genetic context before week one.

Ohio's GLP-1 coverage fractured in 2025-2026 — State of Ohio employee plan, OSU Health Plan, and Ohio Medicaid all narrowed weight-loss GLP-1 access. This guide walks the cash-pay landscape, Ohio telehealth law, compounded vs FDA-approved options, and where PlexusDx Weight Management Protocols ($129/mo flat to) fit for Ohio residents.

NH Medicaid dropped GLP-1 weight-loss coverage on January 1, 2026. Here’s the cash-pay landscape for New Hampshire residents in 2026 — telehealth eligibility, real prices from $129 to $1,349/mo, compounded vs FDA-approved trade-offs, and where PlexusDx Weight Management Protocols fit.

Kentucky residents have three paths to GLP-1 weight-loss therapy in 2026: brand-name FDA-approved medication (Wegovy, Zepbound) at retail or Lilly Direct, in-person clinical care through systems like UK HealthCare Turfland, and cash-pay compounded telehealth. Kentucky Medicaid does not cover GLP-1 for weight loss. PlexusDx Weight Management Protocols ship to all 120 Kentucky counties from $129/mo flat with no membership fee.

The full 2026 GLP-1 cost map: Wegovy, Ozempic, Zepbound, and Mounjaro at branded list price; Lilly Direct and NovoCare manufacturer self-pay programs ($149–$499/mo); cash-pay compounded telehealth alternatives. PlexusDx Weight Management Protocols span $129/mo to $349/mo with all-inclusive pricing, no membership, all 50 states.

Foundayo costs $25/month with covered commercial insurance, $50/month on the Medicare GLP-1 Bridge, or $149-$289/mo self-pay through LillyDirect. Most commercial plans don't cover GLP-1s for weight loss in 2026. Compare cash-pay PlexusDx Weight Management Protocols — Microdose at $129/mo flat, Semaglutide Injection $189/mo, Tirzepatide Injection $289/mo — with no membership fee.

Eden vs Ro vs PlexusDx for cash-pay GLP-1: Eden's $298 advertised semaglutide runs $198/mo all-in with its required membership (verified July 2026); Ro pairs a $149/mo membership with branded medication billed on top; PlexusDx runs $129/mo to $349/mo month to month with an optional genetic baseline.

MEDVi charges no separate membership fee on its compounded semaglutide and tirzepatide programs, where medication is included in one recurring price. Its branded Wegovy and Zepbound pathway is different: a separate monthly membership plus the medication cost. This guide answers the question by plan type and lists the recurring charges to check before you pay.

Compare the best online tirzepatide providers in 2026 — Ro, Eden, Yucca Health, Willow, Sesame — against the PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo) Protocols, with a genetic baseline option no other provider offers.

Medicare Part D is statutorily prohibited from covering GLP-1s prescribed solely for weight loss, and manufacturer copay cards are off-limits to Medicare beneficiaries. This guide explains the Medicare GLP-1 Bridge launching July 2026, Part D backdoors for diabetes, CVD, and OSA, and the cash-pay options that work today — including PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan.

How PlexusDx Weight Management Protocols compare to the major cash-pay GLP-1 programs in 2026 — Mochi, Eden, MEDVi, Ro, GoodRx Care Direct, NovoCare, and LillyDirect — on price, medication source, membership fees, and total annualized cost.

Compounded tirzepatide provider rankings cycle through MEDVi, Eden, Yucca Health, Willow, and TrimRx. PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo) compare on price, oversight, and genetic-test personalization.

Are GLP-1 pills safe? Four are FDA-approved in 2026 (Rybelsus, Ozempic tablets, Wegovy tablet, Foundayo). Patient-specific compounded oral GLP-1s through licensed pharmacies are a separate lawful category. No-prescription drops and gummies aren't legitimate. Here's the safety framework, the boxed-warning context, and where PlexusDx oral protocols fit.

A buyer-side read of the seven brand-name GLP-1 telehealth providers (Ro, Walgreens, GoodRx, Hims & Hers, PlushCare, Sesame, WeightWatchers) covering true month-one cost, what each dispenses, and how PlexusDx compounded protocols ($129/mo to $349/mo, all-inclusive, no membership) fit when branded coverage isn't accessible.

GLP-1 RA is shorthand for GLP-1 receptor agonist. This guide decodes the abbreviation, explains the hormone and the receptor behind it, lists the medications in the class as of April 2026, covers the shared safety profile, and shows where genetics sit upstream.

Tirzepatide is the generic name, yet no FDA-approved generic tirzepatide product exists as of April 2026. This article untangles the naming paradox, the patent timeline stretching into the mid-2030s, the peptide biosimilar pathway, and the legitimate lower-cost paths that are available to patients now.

With insurance, what you pay for Mounjaro turns on your formulary, the indication on your prescription, and prior authorization. This guide explains how coverage becomes a copay, how a manufacturer savings card stacks on top, what Medicare's separate rules mean, and what your options are if the plan says no.

Advertised Mounjaro discounts can mislead if you do not know the list price and coverage rules they sit on. This overview explains the published price, the two discount routes, how insurance shapes the outcome, and where compounded protocols fit, so the numbers you see make sense.

Searchers pairing GLP-1 with Mounjaro usually want the class-level picture rather than a single product: how the incretin pathway works, why Mounjaro adds a second receptor, which compounds share the family, and the genetic variables that quietly sit upstream of any decision in this space.

Coupons for Mounjaro come in two flavors that people often confuse. This guide separates manufacturer savings cards from pharmacy discount platforms, explains who qualifies for each, and shows how insurance status and the compounding window shape the final counter price.

As of April 2026 there is no FDA-approved generic tirzepatide. This overview explains why patents and the biosimilar pathway delay it, what shoppers actually mean by generic, how compounded formulations differ, and the practical options when cost is the concern.

Tirzepatide 5 mg is the second step in the label-directed titration schedule and often the first maintenance-range dose. This page explains where 5 mg sits, what patients commonly report at this step, how timing works, warning signs to watch, and the genetic context beneath it.